➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Johnson and Johnson
Express Scripts
Harvard Business School
AstraZeneca

Last Updated: May 8, 2021

DrugPatentWatch Database Preview

Patent: 10,010,585

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,010,585
Title:Methods of treating vestibular schwannoma and reducing hearing or neurite loss caused by vestibular schwannoma
Abstract: Methods to reduce the proliferation of vestibular schwannoma (VS) cells and/or provide neuroprotection to reduce the risk of sensorineural hearing loss (SNHL), vestibular dysfunction and facial nerve paralysis in subjects with VS. The methods can include one or more of decreasing TNF-.alpha. activity or expression; decreasing NF-.kappa.B expression or activity; decreasing COX-2 expression or activity; administering FGF2; decreasing HGF expression or activity; or decreasing c-Met expression or activity.
Inventor(s): Stankovic; Konstantina (Boston, MA), Dilwali; Sonam (Dallas, TX)
Assignee: Massachusetts Eye and Ear Infirmary (Boston, MA)
Application Number:14/741,332
Patent Claims:see list of patent claims

Details for Patent 10,010,585

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Janssen Biotech SIMPONI ARIA golimumab INJECTABLE; INJECTION 125433 001 2013-07-18   Get Started for $10 Massachusetts Eye and Ear Infirmary (Boston, MA) 2034-06-16 RX search
Centocor Ortho Biotech Inc SIMPONI golimumab INJECTABLE; INJECTION 125289 001 2009-04-24   Get Started for $10 Massachusetts Eye and Ear Infirmary (Boston, MA) 2034-06-16 RX Orphan search
Abbvie Inc HUMIRA adalimumab VIAL 125057 002 2002-12-31   Get Started for $10 Massachusetts Eye and Ear Infirmary (Boston, MA) 2034-06-16 RX search
Abbvie Inc HUMIRA adalimumab SYRINGE 125057 001 2002-12-31   Get Started for $10 Massachusetts Eye and Ear Infirmary (Boston, MA) 2034-06-16 RX search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02   Get Started for $10 Massachusetts Eye and Ear Infirmary (Boston, MA) 2034-06-16 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Boehringer Ingelheim
Colorcon
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.